Neonatal epilepsy syndromes and generalized epilepsy with febrile seizures plus (GEFS+)

Epilepsia

Volumn 46, Issue SUPPL. 10, 2005, Pages 41-47

  Scheffer, Ingrid E ^a,b,c,f   Harkin, Louise A ^d,e   Dibbens, Leanne M ^d,e   Mulley, John C ^d,e   Berkovic, Samuel F ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CLOBAZAM; CYTOCHROME P450; LAMOTRIGINE; PROTEIN GABRD; PROTEIN GABRG2; PROTEIN SCN1A; RECEPTOR SUBUNIT; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; VOLTAGE GATED SODIUM CHANNEL; 4 AMINOBUTYRIC ACID B RECEPTOR; GABRD PROTEIN, HUMAN; GABRR2 PROTEIN, HUMAN; KCNQ2 PROTEIN, HUMAN; NERVE PROTEIN; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; SCN1B PROTEIN, HUMAN; SODIUM CHANNEL; SODIUM CHANNEL, VOLTAGE GATED, TYPE I, ALPHA PROTEIN; SODIUM CHANNEL, VOLTAGE-GATED, TYPE I, ALPHA PROTEIN;

AUTOSOMAL DOMINANT DISORDER; BENIGN CHILDHOOD EPILEPSY; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; FEBRILE CONVULSION; GENE MUTATION; GENERALIZED EPILEPSY; HUMAN; INTRACTABLE EPILEPSY; MYOCLONIC ASTATIC EPILEPSY; MYOCLONUS EPILEPSY; NEWBORN; NEWBORN DISEASE; PHENOTYPE; PRIORITY JOURNAL; SEVERE MYOCLONIC EPILEPSY OF INFANCY; COMPARATIVE STUDY; FEMALE; GENETIC HETEROGENEITY; GENETICS; INFANT; MALE; MUTATION; PRESCHOOL CHILD; REVIEW;

CHILD, PRESCHOOL; EPILEPSIES, MYOCLONIC; EPILEPSY, BENIGN NEONATAL; EPILEPSY, GENERALIZED; FEMALE; GENETIC HETEROGENEITY; HUMANS; INFANT; KCNQ2 POTASSIUM CHANNEL; KCNQ3 POTASSIUM CHANNEL; MALE; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SEIZURES, FEBRILE; SODIUM CHANNELS;

EID: 33644800768     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2005.00358.x     Document Type: Conference Paper

References (83)

1. ILAE. Commission on Classification and Terminology of the International League Against Epilepsy: proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
2. Rett A, Teubel R. Neugeborenenkrämpfe im Rahmen einer epileptisch belasteten familie. Wien Klin Wochenschr 1964;76:609-13.
3. Plouin P, Anderson VE. Benign familial and non-familial neonatal seizures. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. Eastleigh: John Libbey & Co Ltd, 2002:3-13.
4. Ronen GM, Rosales TO, Connolly Y, et al. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 1993;43:1355-60.
5. Singh NA, Westenskow P, Charlier C, et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003;126:2726-37.
6. Hirsch E, Velez A, Sellal F, et al. Electroclinical signs of benign neonatal familial convulsions. Ann Neurol 1993;34:835-41.
7. Bye AME. Neonate with benign familial neonatal convulsions: recorded generalized and focal seizures. Pediatr Neurol 1994;10:164-5.
8. Tang B, Li H, Xia K, et al. A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family. J Neurol Sci 2004;221:31-4.
9. Maihara T, Tsuji M, Higuchi Y, et al. Benign familial neonatal convulsions followed by benign epilepsy with centrotemporal spikes in two siblings. Epilepsia 1999;40:110-3.
10. Lee WL, Biervert C, Hallmann K, et al. A KCNQ2 splice site mutation causing benign neonatal convulsions in a Scottish family. Neuropediatrics 2000;31:9-12.
11. Borgatti R, Zucca C, Cavallini A, et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation. Neurology 2004;63:57-65.
12. Dedek K, Fusco L, Teloy N, et al. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res 2003;54:21-7.
13. Dedek K, Kunath B, Kananura C, et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci U S A 2001;98:12272-7.
14. Biervert C, Schroeder BC, Kubisch C, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-06.
15. Charlier C, Singh NA, Ryan SG, et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998;18:53-5.
16. Singh NA, Charlier C, Stauffer D, et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998;18:25-9.
17. Lerche H, Biervert C, Alekov AK, et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 1999;46:305-12.
18. Miraglia del Giudice E, Coppola G, Scuccimarra G, et al. Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor. Eur J Hum Genet 2000;8:994-7.
19. Hirose S, Zenri F, Akiyoshi H, et al. A novel mutation of KCNQ3 (c.925T→C) in a Japanese family with benign familial neonatal convulsions. Ann Neurol 2000;47:822-6.
20. Richards MC, Heron SE, Spendlove HE, et al. Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction. J Med Genet 2004;41:e35.
21. Claes LR, Ceulemans B, Audenaert D, et al. De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 2004;63:2155-8.
22. Schroeder BC, Kubisch C, Stein V, et al. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. Nature 1998;396:687-90.
23. Schwake M, Pusch M, Kharkovets T, et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy. J Biol Chem 2000;275:13343-8.
24. Cooper EC. Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs. Epilepsia 2001;42:49-54.
25. Castaldo P, del Giudice EM, Coppola G, et al. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J Neurosci 2002;22:RC199.
26. Coppola G, Castaldo P, Miraglia del Giudice E, et al. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes. Neurology 2003;61:131-4.
27. Fukuyama Y. Borderland of childhood epilepsy, with special references to febrile convulsions and so-called infantile convulsions. Seishin Igaku 1963;5:211-23.
28. Vigevano F, Fusco L, Di Capua M, et al. Benign infantile familial convulsions. Eur J Pediatr 1992;151:608-12.
29. Vigevano F, Bureau M. Idiopathic and/or benign localization-related epilepsies in infants and young children. In: Roger JBM, Dravet C, Genton P, Tassinari CA, Wolf P, ed. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. Eastleigh: John Libbey & Co Ltd, 2002:153.
30. Callenbach PM, de Coo RF, Vein AA, et al Benign familial infantile convulsions: a clinical study of seven Dutch families. Eur J Paediatr Neurol 2002;6:269-83.
31. Szepetowski P, Rochette J, Berquin P, et al. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am J Hum Genet 1997;61:889-98.
32. Caraballo R, Pavek S, Lemainque A, et al. Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 2001;68:788-94.
33. Lee WL, Tay A, Ong HT, et al. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Hum Genet 1998;103:608-12.
34. Guipponi M, Rivier F, Vigevano F, et al. Linkage mapping of benign familial infantile convulsions (BFIC) to chromosome 19q. Hum Mol Genet 1997;6:473-7.
35. Vanmolkot KR, Kors EE, Hottenga JJ, et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 2003;54:360-6.
36. Kaplan RE, Lacey DJ. Benign Familial Neonatal-Infantile Seizures. Am J Med Genet 1983;16:595-9.
37. Heron SE, Crossland KM, Andermann E, et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002;360:851-2.
38. Berkovic SF, Heron SE, Giordano L, et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 2004;55:550-7.
39. Malacarne M, Gennaro E, Madia F, et al. Benign familial infantile convulsions: mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity. Am J Hum Genet 2001;68:1521-6.
40. Sugawara T, Tsurubuchi Y, Agarwala KL, et al. A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 2001;98:6384-9.
41. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 1997;120:479-90.
42. Singh R, Scheffer IE, Crossland K, et al. Generalized epilepsy with febrile seizures plus: a common, childhood onset, genetic epilepsy syndrome. Ann Neurol 1999;45:75-81.
43. Wallace RH, Wang DW, Singh R, et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+ channel beta1 subunit gene SCN1B. Nat Genet 1998;19:366-70.
44. Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet 2001;68:859-65.
45. Escayg A, MacDonald BT, Meisler MH, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 2000;24:343-5.
46. Baulac S, Huberfeld G, Gourfinkel-An I, et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 2001;28:46-8.
47. Marini C, Harkin LA, Wallace RH, et al. Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation. Brain 2003;126:230-40.
48. Bonanni P, Malcarne M, Moro F, et al. Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations. Epilepsia 2004;45:149-158.
49. Abou-Khalil B, Ge Q, Desai R, et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology 2001;57:2265-72.
50. Wallace R, Scheffer IE, Parasivam G, et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 2002;58:1426-9.
51. Scheffer IE, Wallace R, Wellard MR, et al. Temporal lobe epilepsy and febrile seizures associated with a sodium channel beta 1 subunit (SCN1B) mutation. Epilepsia 2000;41:71.
52. Baulac S, Gourfinkel-An I, Picard F, et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am J Hum Genet 1999;65:1078-85.
53. Doose H, Gerken H, Leonhardt R, et al. Centrencephalic myoclonicastatic petit mal. Neuropediatrics 1970;2:59-78.
54. Doose H. Myoclonic astatic epilepsy of early childhood. In: Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 2 ed. London: John Libbey & Company Ltd, 1992:103-14.
55. Guerrini R, Parmeggiani L, Kaminska A, et al. Myoclonic astatic epilepsy. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. 3rd ed. Eastleigh: John Libbey & Co Ltd, 2002:105-12.
56. Guerrini R, Aicardi J. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J Clin Neurophysiol 2003;20:449-61.
57. Doose H, Baier WK. Genetic factors in epilepsies with primarily generalized minor seizures. J Pediatr Neurobiol Neurol Neurosurg 1987;18(Suppl I):1-64.
58. Wallace RH, Marini C, Petrou S, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001;28:49-52.
59. Nabbout R, Kozlovski A, Gennaro E, et al. Absence of mutations in major GEFS+ genes in myoclonic astatic epilepsy. Epilepsy Res 2003;56:127-33.
60. Mulley J, Scheffer I, Petrou S, et al. SCN1A mutations and epilepsy. Hum Mutat 2005;25:535-42.
61. Scheffer IE, Wallace RH, Dibbens L, et al. TLE associated with mutations of the gene encoding the regulatory subunit of the sodium channel in GEFS+. Epilepsia 2003;44:173-4.
62. Audenaert D, Claes L, Ceulemans B, et al. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 2003;61:854-6.
63. Harkin LA, Bowser DN, Dibbens LM, et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 2002;70:530-6.
64. Kananura C, Haug K, Sander T, et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 2002;59:1137-41.
65. Dibbens LM, Feng HJ, Richards MC, et al. GABRD encoding a protein for extra- or peri-synaptic GABA(A) receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 2004;13:1315-9.
66. Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42:796-803.
67. Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-32.
68. Sugawara T, Mazaki-Miyazaki E, Fukushima K, et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 2002;58:1122-4.
69. Claes L, Ceulemans B, Audenaert D, et al. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 2003;21:615-21.
70. Fujiwara T, Sugawara T, Mazaki-Miyazaki E, et al. Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 2003;126:531-46.
71. Fukuma G, Oguni H, Shirasaka Y, et al. Genetic abnormalities in core severe myoclonic epilepsy of infancy (SMEI) and borderline SMEI (SMEB). Abstr 25th Int Epilepsy Congr 2003;44:50.
72. Gennaro E, Veggiotti P, Malacarne M, et al. Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. Epileptic Disord 2003;5:21-5.
73. Nabbout R, Gennaro E, Dalla Bernardina B, et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 2003;60:1961-7.
74. Fukuma G, Oguni H, Shirasaka Y, et al. Mutations of neuronal voltage-gated Na+ channel alpha 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia 2004;45:140-8.
75. Wallace R, Hodgson BL, Grinton BE, et al. Sodium channel alpha-1 subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 2003;61:765-9.
76. Dravet C, Bureau M, Roger J. Severe myoclonic epilepsy in infants. In: Roger J, Dravet C, Bureau M, Dreifuss FE, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey Eurotext Ltd, 1985:58-104.
77. Singh R, Andermann E, Whitehouse WPA, et al. Severe myoclonic epilepsy of infancy: extended spectrum of GEFS+? Epilepsia 2001;42:837-44.
78. Veggiotti P, Cardinali S, Montalenti E, et al. Generalized epilepsy with febrile seizures plus and severe myoclonic epilepsy in infancy: a case report of two Italian families. Epileptic Disord 2001;3:29-32.
79. Scheffer IE. Severe infantile epilepsies: molecular genetics challenge clinical classification. Brain 2003;126:513-14.
80. Kamiya K, Kaneda M, Sugawara T, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci 2004;24:2690-8.
81. Guerrini R, Dravet C, Genton P, et al. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998;39s:508-12.
82. Chiron C, Marchand MC, Tran A, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-42.
83. Coppola G, Capovilla G, Montagnini A, et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res 2002;49:45-8.